Oracle acquisition of software firm will pump up its portfolio

04/19/2010 | Boston Globe (tiered subscription model), The

Oracle plans to augment its drug research software portfolio by acquiring Phase Forward, a firm that offers clinical trial management software. The $685 million deal should close by mid-year and will bring together "some of the best-of-breed products into one solution," an official from IDC Health Insights said.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ